title: Characterization of a granule-independent lytic mechanism used by CTL hybridomas.
abstract: The mechanism(s) by which CTL induce target cell lysis have not been clearly elucidated. Perforin and the cytotoxic cell proteinases (granzymes) contained within the granules of CTL and NK, have been implicated, but abundant evidence for the existence of alternate lytic pathways has accumulated. In this report we characterize the mechanism of killing used by two cytolytic hybridomas (PMM-1 and MD90) that express neither perforin nor the granzymes. These characteristics are compared with results obtained by using a representative Ag-dependent, granule-containing T cell clone in cytolysis assays. The major differences were that the granule-negative hybridomas could lyse a variety of target cells in the presence of cyclosporin and the absence of calcium. All the effectors could kill in the presence of protein synthesis inhibitors (cycloheximide and emetine) and induced DNA fragmentation in the target cells. The cytolytic hybridomas had to be stimulated to be cytolytic and this activation required the presence of calcium, was dependent on protein synthesis, and inhibited by the addition of cyclosporin. Although TNF was shown not be involved, the sensitivity of the target cells to lysis by the granule-negative killers correlated with the level of expression of Fas Ag. With the use of L1210 and an L1210 cell line transfected with Fas cDNA we demonstrated that these MD90 and PMM-1 kill the latter much more effectively and that this increase was effectively inhibited with anti-Fas Ab. Furthermore the lack of sensitivity to cyclosporin, cycloheximide, emetine, and EGTA was confirmed with these targets. We conclude that these two cytolytic hybridomas use the Fas lytic pathway to induce lysis in target cells.
authors.affiliation: Department of Biochemistry, University of Alberta, Edmonton, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Garner
authors.forename: C D
authors.initials: CD
authors.lastname: Helgason
authors.forename: E A
authors.initials: EA
authors.lastname: Atkinson
authors.forename: M J
authors.initials: MJ
authors.lastname: Pinkoski
authors.forename: H L
authors.initials: HL
authors.lastname: Ostergaard
authors.forename: O
authors.initials: O
authors.lastname: Sorensen
authors.forename: A
authors.initials: A
authors.lastname: Fu
authors.forename: P H
authors.initials: PH
authors.lastname: Lapchak
authors.forename: A
authors.initials: A
authors.lastname: Rabinovitch
authors.forename: J E
authors.initials: JE
authors.lastname: McElhaney
mesh_terms: D000818:Animals; D000954:Antigens, Surface / Q000276:immunology*; D002118:Calcium / Q000502:physiology; D016572:Cyclosporine / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D004247:DNA / Q000032:analysis; D053804:Granzymes; D006825:Hybridomas; D008562:Membrane Glycoproteins / Q000276:immunology; D051379:Mice; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D012697:Serine Endopeptidases / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D019014:fas Receptor
chemical_list: D000954:Antigens, Surface; D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor; D054353:Perforin; D016572:Cyclosporine; D004247:DNA; D053804:Granzymes; D012697:Serine Endopeptidases; D002118:Calcium